Tomáš Vaisar

8.5k total citations · 1 hit paper
127 papers, 4.7k citations indexed

About

Tomáš Vaisar is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Tomáš Vaisar has authored 127 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Endocrinology, Diabetes and Metabolism, 46 papers in Molecular Biology and 43 papers in Surgery. Recurrent topics in Tomáš Vaisar's work include Diabetes, Cardiovascular Risks, and Lipoproteins (42 papers), Lipoproteins and Cardiovascular Health (20 papers) and Mass Spectrometry Techniques and Applications (20 papers). Tomáš Vaisar is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (42 papers), Lipoproteins and Cardiovascular Health (20 papers) and Mass Spectrometry Techniques and Applications (20 papers). Tomáš Vaisar collaborates with scholars based in United States, Czechia and Brazil. Tomáš Vaisar's co-authors include Jay W. Heinecke, Christine L. Gatlin, František Tureček, Graziella E. Ronsein, Andrew N. Hoofnagle, Alan Chait, Ján Urban, Lev Becker, Michael N. Oda and Patrick M. Hutchins and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Tomáš Vaisar

124 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis

2021 216 citations Catherine A. Reardon, Tomáš Vaisar et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tomáš Vaisar United States	43	1.6k	1.3k	1.2k	953	849	127	4.7k
Michael N. Oda United States	38	1.7k 1.1×	1.4k 1.1×	1.3k 1.1×	518 0.5×	216 0.3×	73	4.1k
G.M. Anantharamaiah United States	34	1.8k 1.1×	2.1k 1.6×	1.6k 1.3×	635 0.7×	145 0.2×	70	4.9k
David A. Ford United States	42	3.4k 2.1×	867 0.7×	400 0.3×	1.4k 1.5×	304 0.4×	169	6.6k
Katariina Öörni Finland	33	2.2k 1.4×	1.5k 1.2×	685 0.6×	1.9k 2.0×	122 0.1×	110	5.4k
Joel D. Morrisett United States	47	3.3k 2.1×	2.9k 2.3×	1.7k 1.4×	701 0.7×	353 0.4×	167	8.3k
Eugene A. Podrez United States	34	2.7k 1.7×	1.3k 1.0×	421 0.3×	2.8k 2.9×	204 0.2×	76	6.9k
Amir Ravandi Canada	36	1.2k 0.7×	999 0.8×	442 0.4×	594 0.6×	129 0.2×	145	3.8k
Germán Camejo Sweden	42	2.0k 1.2×	1.5k 1.2×	1.1k 0.9×	1.1k 1.1×	106 0.1×	113	5.1k
Julio C. Medina United States	29	2.3k 1.4×	2.2k 1.8×	434 0.4×	671 0.7×	218 0.3×	78	5.0k
Teake Kooistra Netherlands	40	2.0k 1.3×	1.4k 1.1×	599 0.5×	1.7k 1.7×	112 0.1×	97	6.4k

Countries citing papers authored by Tomáš Vaisar

Since Specialization

Citations

This map shows the geographic impact of Tomáš Vaisar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomáš Vaisar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomáš Vaisar more than expected).

Fields of papers citing papers by Tomáš Vaisar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomáš Vaisar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomáš Vaisar. The network helps show where Tomáš Vaisar may publish in the future.

Co-authorship network of co-authors of Tomáš Vaisar

This figure shows the co-authorship network connecting the top 25 collaborators of Tomáš Vaisar. A scholar is included among the top collaborators of Tomáš Vaisar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomáš Vaisar. Tomáš Vaisar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hill, John H., Jamie Morris, Kelly A. Manthei, et al.. (2025). Lecithin:cholesterol acyltransferase binds a discontinuous binding site on adjacent apolipoprotein A-I belts in HDL. Journal of Lipid Research. 66(5). 100786–100786. 1 indexed citations

Guan, Pujun, Ripon Sarkar, Yang Yu, et al.. (2025). Focal Adhesion Kinase Drives Rho/ROCK and mTOR Signaling to Protect and Augment Aortic Dissections. JACC Basic to Translational Science. 10(9). 101353–101353.

Kothari, Vishal, Ainara G. Cabodevilla, Yi He, et al.. (2024). Imbalance of APOB Lipoproteins and Large HDL in Type 1 Diabetes Drives Atherosclerosis. Circulation Research. 135(2). 335–349. 5 indexed citations

Shao, Baohai, Masami Shimizu‐Albergine, Farah Kramer, et al.. (2024). A targeted proteomics method for quantifying plasma apolipoprotein kinetics in individual mice using stable isotope labeling. Journal of Lipid Research. 65(4). 100531–100531.

Attah, Isaac, C Bunch, Irina Novikova, et al.. (2024). APOA2 increases cholesterol efflux capacity to plasma HDL by displacing the C-terminus of resident APOA1. Journal of Lipid Research. 65(12). 100686–100686. 3 indexed citations

Costacou, Tina, Rachel G. Miller, Karin Bornfeldt, et al.. (2024). Sex differences in the associations of HDL particle concentration and cholesterol efflux capacity with incident coronary artery disease in type 1 diabetes: The RETRO HDLc cohort study. Journal of clinical lipidology. 18(2). e218–e229. 6 indexed citations

He, Yi, Chiara Pavanello, Patrick M. Hutchins, et al.. (2023). Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs. Circulation. 149(10). 774–787. 17 indexed citations

Rosenson, Robert S., Mary Cushman, Emily McKinley, et al.. (2023). Association Between Triglycerides and Incident Cognitive Impairment in Black and White Adults in the Reasons for Geographic and Racial Differences in Stroke Study. Journal of the American Heart Association. 12(5). e026833–e026833. 1 indexed citations

Yoshida, Teruhiko, Clark M. Henderson, Joshua A. Lieberman, et al.. (2022). Variant APOL1 protein in plasma associates with larger particles in humans and mouse models of kidney injury. PLoS ONE. 17(10). e0276649–e0276649. 4 indexed citations

10.

Josefs, Tatjana, Debapriya Basu, Tomáš Vaisar, et al.. (2021). Atherosclerosis Regression and Cholesterol Efflux in Hypertriglyceridemic Mice. Circulation Research. 128(6). 690–705. 14 indexed citations

11.

Gordon, Scott M., Marcelo Amar, Michael Stagliano, et al.. (2020). Effect of niacin monotherapy on high density lipoprotein composition and function. Lipids in Health and Disease. 19(1). 190–190. 17 indexed citations

12.

Vaisar, Tomáš, Jennifer L. Gordon, Jake Wimberger, et al.. (2020). Perimenopausal transdermal estradiol replacement reduces serum HDL cholesterol efflux capacity but improves cardiovascular risk factors. Journal of clinical lipidology. 15(1). 151–161.e0. 6 indexed citations

13.

Kanter, Jenny E., Baohai Shao, Farah Kramer, et al.. (2019). Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes. Journal of Clinical Investigation. 129(10). 4165–4179. 77 indexed citations

14.

Vaisar, Tomáš, Jenny E. Kanter, Jake Wimberger, et al.. (2019). High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 Diabetes. Diabetes Care. 43(1). 178–186. 46 indexed citations

15.

Scolaro, Bianca, Marina Sayuri Nogueira, Adriana Bertolami, et al.. (2018). Statin dose reduction with complementary diet therapy: A pilot study of personalized medicine. Molecular Metabolism. 11. 137–144. 19 indexed citations

16.

Pamir, Nathalie, Patrick M. Hutchins, Graziella E. Ronsein, et al.. (2017). Plasminogen promotes cholesterol efflux by the ABCA1 pathway. JCI Insight. 2(15). 36 indexed citations

17.

Becker, Lev, Sina A. Gharib, Angela D. Irwin, et al.. (2010). A Macrophage Sterol-Responsive Network Linked to Atherogenesis. Cell Metabolism. 11(2). 125–135. 65 indexed citations

18.

Chang, Dong, Shinichi Hayashi, Sina A. Gharib, et al.. (2008). Proteomic and Computational Analysis of Bronchoalveolar Proteins during the Course of the Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 178(7). 701–709. 63 indexed citations

19.

Křen, Vladimı́r, Aleš Svatoš, Tomáš Vaisar, et al.. (1993). Fructosylation of ergot alkaloids by submerged cultures of Claviceps purpurea inhibited in alkaloid production. Journal of Chemical Research Synopses. 1 indexed citations

20.

Morgan, E. David, Bert H�lldobler, Tomáš Vaisar, & Brian D. Jackson. (1992). Contents of poison apparatus and their relation to trail-following in the antDaceton armigerum. Journal of Chemical Ecology. 18(12). 2161–2168. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact